567 related articles for article (PubMed ID: 11522624)
21. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
[TBL] [Abstract][Full Text] [Related]
22. Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes.
Cherpillod P; Amstad PA
Mol Carcinog; 1995 May; 13(1):15-20. PubMed ID: 7766306
[TBL] [Abstract][Full Text] [Related]
23. p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA.
Wang Y; Zhou X; Weinstein E; Maryles B; Zhang Y; Moore J; Gao D; Atencio DP; Rosenstein BS; Lebwohl M; Chen HD; Xiao T; Wei H
Photochem Photobiol; 2008; 84(2):444-9. PubMed ID: 18248503
[TBL] [Abstract][Full Text] [Related]
24. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits.
Pandima Devi K; Sivamaruthi B; Kiruthiga PV; Karutha Pandian S
Hum Exp Toxicol; 2010 Jun; 29(6):451-8. PubMed ID: 19948747
[TBL] [Abstract][Full Text] [Related]
25. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.
Denissenko MF; Pao A; Tang M; Pfeifer GP
Science; 1996 Oct; 274(5286):430-2. PubMed ID: 8832894
[TBL] [Abstract][Full Text] [Related]
26. In silico p53 mutation hotspots in lung cancer.
Lewis PD; Parry JM
Carcinogenesis; 2004 Jul; 25(7):1099-107. PubMed ID: 14729588
[TBL] [Abstract][Full Text] [Related]
27. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.
Conway K; Edmiston SN; Cui L; Drouin SS; Pang J; He M; Tse CK; Geradts J; Dressler L; Liu ET; Millikan R; Newman B
Cancer Res; 2002 Apr; 62(7):1987-95. PubMed ID: 11929815
[TBL] [Abstract][Full Text] [Related]
29. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
[TBL] [Abstract][Full Text] [Related]
30. Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis.
Hu W; Feng Z; Tang MS
Carcinogenesis; 2004 Mar; 25(3):455-62. PubMed ID: 14604891
[TBL] [Abstract][Full Text] [Related]
31. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.
Spruck CH; Rideout WM; Olumi AF; Ohneseit PF; Yang AS; Tsai YC; Nichols PW; Horn T; Hermann GG; Steven K
Cancer Res; 1993 Mar; 53(5):1162-6. PubMed ID: 8439962
[TBL] [Abstract][Full Text] [Related]
32. Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection.
Shen YM; Troxel AB; Vedantam S; Penning TM; Field J
Chem Res Toxicol; 2006 Nov; 19(11):1441-50. PubMed ID: 17112231
[TBL] [Abstract][Full Text] [Related]
33. Base damage, local sequence context and TP53 mutation hotspots: a molecular dynamics study of benzo[a]pyrene induced DNA distortion and mutability.
Menzies GE; Reed SH; Brancale A; Lewis PD
Nucleic Acids Res; 2015 Oct; 43(19):9133-46. PubMed ID: 26400171
[TBL] [Abstract][Full Text] [Related]
34. p53 mutations in human lung tumors.
Miller CW; Simon K; Aslo A; Kok K; Yokota J; Buys CH; Terada M; Koeffler HP
Cancer Res; 1992 Apr; 52(7):1695-8. PubMed ID: 1312896
[TBL] [Abstract][Full Text] [Related]
35. Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients.
Gao W; Mady HH; Melhem MF; Keohavong P
Mol Carcinog; 2009 Jul; 48(7):633-41. PubMed ID: 19072763
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.
Xiong P; Bondy ML; Li D; Shen H; Wang LE; Singletary SE; Spitz MR; Wei Q
Cancer Res; 2001 Dec; 61(23):8465-9. PubMed ID: 11731429
[TBL] [Abstract][Full Text] [Related]
37. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.
Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P
Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884
[TBL] [Abstract][Full Text] [Related]
38. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
[TBL] [Abstract][Full Text] [Related]
39. Formation of lysine 63-linked poly-ubiquitin chains protects human lung cells against benzo[a]pyrene-diol-epoxide-induced mutagenicity.
Langie SA; Knaapen AM; Ramaekers CH; Theys J; Brun J; Godschalk RW; van Schooten FJ; Lambin P; Gray DA; Wouters BG; Chiu RK
DNA Repair (Amst); 2007 Jun; 6(6):852-62. PubMed ID: 17395554
[TBL] [Abstract][Full Text] [Related]
40. Formation of benzo[a]pyrene diol epoxide-DNA adducts at specific guanines within K-ras and p53 gene sequences: stable isotope-labeling mass spectrometry approach.
Tretyakova N; Matter B; Jones R; Shallop A
Biochemistry; 2002 Jul; 41(30):9535-44. PubMed ID: 12135376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
